DHT blocker therapy mechanism, effectiveness benchmarks (finasteride ~60%, dutasteride ~80% responder rates), FDA approval status, side effects, and clinic selection criteria for Hyderabad.

DHT blocker therapy with finasteride and dutasteride halts hair loss in 80-90% of men. Evidence-based guide to effectiveness, timelines, and choosing clinics in Hyderabad with physician-prescribed protocols.

DHT blocker therapy uses prescription medications to inhibit dihydrotestosterone, the hormone primarily responsible for androgenetic alopecia in both men and women. TL;DR DHT blocker therapy targets the root hormonal cause of androgenetic alopecia by inhibiting the enzyme 5-alpha-reductase, which converts testosterone to DHT [1] Finasteride shows effectiveness in 68% of men with pattern baldness over 24 months, while dutasteride demonstrates stronger DHT suppression but requi